These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 5318642)

  • 41. [Emergency medical aid in bronchospasm].
    Ermakov EV; Zakhorov MP; Barskiĭ RL
    Voen Med Zh; 1977 Feb; (2):27-31. PubMed ID: 867889
    [No Abstract]   [Full Text] [Related]  

  • 42. A comparison of isoetharine and albuterol: report of changes in pulmonary functions over 1 hour.
    Yates T; Dubin B; Bell-Jesion C
    J Am Osteopath Assoc; 1982 Apr; 81(8):546-8. PubMed ID: 7042663
    [No Abstract]   [Full Text] [Related]  

  • 43. [The bronchoexpanding effects of phenylephrine and its combination with isoprenaline in comparison with other bronchodilator agents].
    Langer I
    Acta Allergol; 1967 Dec; 22(6):419-46. PubMed ID: 5630525
    [No Abstract]   [Full Text] [Related]  

  • 44. A new mode of administration of nebulized bronchodilator in severe bronchospasm.
    Andersen JB; Klausen NO
    Eur J Respir Dis Suppl; 1982; 119():97-100. PubMed ID: 7047190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Contribution to the treatment of spastic bronchitis in infancy].
    Habermann P
    Med Welt; 1968 May; 21():1342-4. PubMed ID: 5721333
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of salbutamol on lung volumes in bronchial asthma.
    Cueva Velazquez J; Salazar Mallen M; Celis A; Cicero R
    Postgrad Med J; 1971 Mar; 47():Suppl:100-5. PubMed ID: 5572506
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effects of bamifylline and of combined bamifylline and phenylpropanolamine in reversible respiratory obstruction].
    Billiet L; Moia V; Prignot J
    Acta Tuberc Pneumol Belg; 1971; 62(2):204-10. PubMed ID: 4939584
    [No Abstract]   [Full Text] [Related]  

  • 48. [The influence of orciprenaline on the regional relationships between ventilation and perfusion in irreversible bronchial obstruction].
    Stiksa J; Daum S; Nikodýmová L
    Arzneimittelforschung; 1967 May; 17(5):568-72. PubMed ID: 5631586
    [No Abstract]   [Full Text] [Related]  

  • 49. Exercise-induced bronchospasm: comparison of bronkephrine and epinephrine.
    Sly RM; Schlumbrecht L
    Ann Allergy; 1968 Sep; 26(9):493-8. PubMed ID: 5682240
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of asthma and chronic respiratory insufficiency by AC 3810 (trentadil)].
    Fréour P; Chomy P; Bernadou J; Chidler H
    J Med Bord; 1967 Nov; 114(11):1685-92. PubMed ID: 5602593
    [No Abstract]   [Full Text] [Related]  

  • 51. [Influence of decloxizine on various spirometric indices].
    Blasi A; Di Perna A
    Acta Tuberc Pneumol Belg; 1968; 59(4):591-600. PubMed ID: 5739748
    [No Abstract]   [Full Text] [Related]  

  • 52. [On the treatment of spastic bronchitis in infants and children using a new bronchospasmolytic agent].
    Ertogan F; Stolting G; Russ D
    Dtsch Med J; 1969 Jun; 20(12):413-5. PubMed ID: 5801770
    [No Abstract]   [Full Text] [Related]  

  • 53. Management of status asthmaticus.
    Rees HA
    Postgrad Med J; 1967 Apr; 43(498):225-33. PubMed ID: 4292475
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment of the bronchospastic syndrome].
    Kazanbiev NK; Magomedov AZ; Minkailov KM
    Sov Med; 1986; (10):51-4. PubMed ID: 3544241
    [No Abstract]   [Full Text] [Related]  

  • 55. [Results from comparative study of the bronchodilator effect of decloxizine in patients with reversible bronchospasm].
    Hrouda J; Bogaard JM
    Acta Tuberc Pneumol Belg; 1968; 59(4):742-8. PubMed ID: 5739760
    [No Abstract]   [Full Text] [Related]  

  • 56. [Study of the bronchodilator effect of a new sympathomimetic preparation in measured aerosols].
    Charpin J; Grimaud C; Ohresser P; Boutin C; Aubert J; Casanova P
    Mars Med; 1967; 104(6):585-8. PubMed ID: 5618406
    [No Abstract]   [Full Text] [Related]  

  • 57. [Effect of various broncholytics on bronchial patency and central hemodynamics in patients with pulmonary tuberculosis and other lung diseases].
    Vizel' AA
    Probl Tuberk; 1988; (9):27-31. PubMed ID: 3231618
    [No Abstract]   [Full Text] [Related]  

  • 58. [Clinical experience with hexoprenaline, a new broncholytic agent].
    Hartl O
    Wien Med Wochenschr; 1972 Feb; 122(8):121-6. PubMed ID: 5012665
    [No Abstract]   [Full Text] [Related]  

  • 59. [Bronchospasmolysis without adrenaline effect].
    Harnoncourt K
    Wien Med Wochenschr; 1969 Mar; 119(9):171-4. PubMed ID: 5811147
    [No Abstract]   [Full Text] [Related]  

  • 60. [Bronchodilating effects of an orciprenaline derivative].
    Anastasatu C; Jienescu Z; Duţu S
    Ftiziologia; 1972; 21(6):593-8. PubMed ID: 4644837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.